Woodline Partners’s Medtronic MDT Stock Holding History

Woodline Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.33M	Sell	50,005 -168,833	-77%	-$16.2M	0.02%	682
2025 Q4	$21M	Sell	218,838 -88,810	-29%	-$8.63M	0.08%	302
2025 Q3	$29.3M	Sell	307,648 -168,712	-35%	-$15.5M	0.14%	205
2025 Q2	$41.5M	Buy	476,360 +433,091	+1,001%	+$36.7M	0.22%	131
2025 Q1	$3.89M	Sell	43,269 -257,207	-86%	-$23M	0.03%	565
2024 Q4	$24M	Buy	+300,476	New	+$26M	0.16%	180
2022 Q4	–	Sell	-944,872	Closed	-$76.3M	–	812
2022 Q3	$76.3M	Buy	944,872 +367,291	+64%	+$33M	1.07%	8
2022 Q2	$51.8M	Buy	+577,581	New	+$58.5M	0.8%	19
2021 Q4	–	Sell	-359,728	Closed	-$45.1M	–	755
2021 Q3	$45.1M	Buy	+359,728	New	+$46.6M	0.74%	27
2021 Q1	–	Sell	-586,448	Closed	-$68.7M	–	457
2020 Q4	$68.7M	Buy	586,448 +162,692	+38%	+$17.9M	1.82%	9
2020 Q3	$44M	Buy	+423,756	New	+$42.6M	1.44%	17

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodline Partners's MDT Position: Q1 2026 in Review

Woodline Partners reduced its Medtronic (MDT) stake by 77% in Q1 2026, selling an estimated $16.2M and leaving 50,005 shares worth $4.33M. The position accounts for 0.02% of the portfolio, ranked #682.

Woodline Partners first reported a position in MDT in Q3 2020 and has held it in 11 quarters since. The position peaked at $76.3M in Q3 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Woodline Partners held 50,005 shares of Medtronic worth $4.33M as of Q1 2026.
Woodline Partners sold 168,833 Medtronic shares in Q1 2026, an estimated $16.2M.
Medtronic made up 0.02% of Woodline Partners's portfolio in Q1 2026, its #682 holding.
Woodline Partners first reported a position in Medtronic in Q3 2020 and has held it in 11 quarters since.
Woodline Partners's Medtronic position peaked at $76.3M in Q3 2022.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.